Reply to Singh on the Prospective Study of Hepatitis  by Sun, Hsin-Yun et al.
900 J Formos Med Assoc | 2009 • Vol 108 • No 11
LETTER TO THE EDITOR
Sir,
We thank Dr Singh for her/his interest in our
work,1 and respond to her/his queries as follows.
First, the incidence of hepatitis did not differ be-
tween patients with pulmonary or extrapulmo-
nary tuberculosis (TB; 14.5% vs. 26.5%, p=0.077).
Second, alternate-day treatment of TB is not 
a common practice in the clinical setting in 
Taiwan, and all study patients received daily
treatment. Therefore, no description was offered
in this regard. Third, all enrolled patients had
newly diagnosed TB. Finally, data on disease
severity were not collected, therefore, further in-
formation could not be offered.
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